Tyra Plummets To 10-Month Low On Mixed Bladder Cancer Results

Tyra stock plummeted to a 10-month low Wednesday on mixed test results for its experimental bladder cancer treatment. The post Tyra Plummets To 10-Month Low On Mixed Bladder Cancer Results appeared first on Investor's Business Daily.